Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug2400 | MinnRAP Peer Support Program Wiki | 0.71 |
| drug563 | Biological collection with nasopharyngeal samples, saliva, blood, stool and urine Wiki | 0.71 |
| drug683 | CBD Isolate Wiki | 0.71 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D000068376 | Compassion Fatigue NIH | 0.50 |
| D000067073 | Psychological Trauma NIH | 0.41 |
| D020920 | Dyssomnias NIH | 0.29 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D020447 | Parasomnias NIH | 0.27 |
| D000437 | Alcoholism NIH | 0.27 |
| D019966 | Substance-Related Disorders NIH | 0.20 |
| D013315 | Stress, Psychological NIH | 0.13 |
| D040921 | Stress Disorders, Traumatic NIH | 0.12 |
| D013313 | Stress Disorders, Post-Traumatic NIH | 0.12 |
| D004194 | Disease NIH | 0.11 |
| D001008 | Anxiety Disorders NIH | 0.10 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There are 2 clinical trials
The Professional Peer Resilience Initiative (PPRI) study is an observational study aimed at understanding how symptoms of traumatic stress and resilience evolve over time in the University of Minnesota (UMN) healthcare workforce during the coronavirus disease 2019 (COVID-19) pandemic. The study is being conducted concurrently with a UMN peer support program called the MinnRAP program and will remotely administer quality of life and mental health surveys to healthcare workers before they start the MinnRAP program and throughout their participation in the program.
Description: Professional Quality of Life Questionnaire (proQOL): min score of 10; max score of 50; higher scores mean worse outcome
Measure: Change in professional quality of life Time: Before peer support program, through study completion (an average of 7 months)Description: Stress Risk & Resilience Self-Index: min score 0; max score of 12; higher scores mean worse outcome
Measure: Change in mental health symptoms and resilience markers Time: Before peer support program, through study completion (an average of 7 months)The overarching objective of the proposed project is to test the relative clinical efficacy of CBD isolate, full-spectrum CBD oil, and placebo in in reducing COVID-Induced stress, anxiety, depression, anger, and sleep disturbance.
Description: This measure is a 23-item patient-rated emotional distress symptom scale consisting of 3 sub-factors (Depression, Anxiety, and Anger). Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Emotional Distress Index Time: Week 0-BaselineDescription: This measure is a 23-item patient-rated emotional distress symptom scale consisting of 3 sub-factors (Depression, Anxiety, and Anger). Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Emotional Distress Index Time: Week 1-TreatmentDescription: This measure is a 23-item patient-rated emotional distress symptom scale consisting of 3 sub-factors (Depression, Anxiety, and Anger). Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Emotional Distress Index Time: Week 2-TreatmentDescription: This measure is a 23-item patient-rated emotional distress symptom scale consisting of 3 sub-factors (Depression, Anxiety, and Anger). Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Emotional Distress Index Time: Week 3-TreatmentDescription: This measure is a 23-item patient-rated emotional distress symptom scale consisting of 3 sub-factors (Depression, Anxiety, and Anger). Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Emotional Distress Index Time: Weeks 4-TreatmentDescription: This measure is a 23-item patient-rated emotional distress symptom scale consisting of 3 sub-factors (Depression, Anxiety, and Anger). Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Emotional Distress Index Time: Week 5-TreatmentDescription: This measure is a 23-item patient-rated emotional distress symptom scale consisting of 3 sub-factors (Depression, Anxiety, and Anger). Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Emotional Distress Index Time: Week 6-TreatmentDescription: This measure is a 23-item patient-rated emotional distress symptom scale consisting of 3 sub-factors (Depression, Anxiety, and Anger). Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Emotional Distress Index Time: Week 7-Follow-upDescription: This measure is a 23-item patient-rated emotional distress symptom scale consisting of 3 sub-factors (Depression, Anxiety, and Anger). Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Emotional Distress Index Time: Week 8-Follow-upDescription: This measure is an 8-item patient-rated depression symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Depression Scale Time: Week 0-BaselineDescription: This measure is an 8-item patient-rated depression symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Depression Scale Time: Week 1-TreatmentDescription: This measure is an 8-item patient-rated depression symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Depression Scale Time: Week 2-TreatmentDescription: This measure is an 8-item patient-rated depression symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Depression Scale Time: Week 3-TreatmentDescription: This measure is an 8-item patient-rated depression symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Depression Scale Time: Week 4-TreatmentDescription: This measure is an 8-item patient-rated depression symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Depression Scale Time: Week 5-Follow-upDescription: This measure is an 8-item patient-rated depression symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Depression Scale Time: Week 6-Follow-upDescription: This measure is an 8-item patient-rated depression symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anxiety Scale Time: Week 0 BaselineDescription: This measure is an 8-item patient-rated depression symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anxiety Scale Time: Week 1-TreatmentDescription: This measure is a 7-item patient-rated anxiety symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anxiety Scale Time: Week 2-TreatmentDescription: This measure is a 7-item patient-rated anxiety symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anxiety Scale Time: Week 3-TreatmentDescription: This measure is a 7-item patient-rated anxiety symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anxiety Scale Time: Week 4-TreatmentDescription: This measure is a 7-item patient-rated anxiety symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anxiety Scale Time: Week 5-Follow-upDescription: This measure is a 7-item patient-rated anxiety symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anxiety Scale Time: Week 6-Follow-upDescription: This measure is an 8-item patient-rated anger symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anger Scale Time: Week 0 BaselineDescription: This measure is an 8-item patient-rated anger symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anger Scale Time: Week 1 TreatmentDescription: This measure is an 8-item patient-rated anger symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anger Scale Time: Week 2 TreatmentDescription: This measure is an 8-item patient-rated anger symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anger Scale Time: Week 3 TreatmentDescription: This measure is an 8-item patient-rated anger symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anger Scale Time: Week 4 TreatmentDescription: This measure is an 8-item patient-rated anger symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anger Scale Time: Week 5 Follow-upDescription: This measure is an 8-item patient-rated anger symptom scale. Each symptom is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Anger Scale Time: Week 6 Follow-upDescription: This measure is an 8-item patient-rated index of alcohol-related problems. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Alcohol Negative Consequences Scale Time: Week 0 BaselineDescription: This measure is an 8-item patient-rated index of alcohol-related problems. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Alcohol Negative Consequences Scale Time: Week 1 TreatmentDescription: This measure is an 8-item patient-rated index of alcohol-related problems. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Alcohol Negative Consequences Scale Time: Week 2 TreatmentDescription: This measure is an 8-item patient-rated index of alcohol-related problems. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Never) to 5 (Always).
Measure: PROMIS Alcohol Negative Consequences Scale Time: Week 3 TreatmentDescription: This measure is an 8-item patient-rated index of substance use severity. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Not at all) to 5 (Almost Always).
Measure: PROMIS Alcohol Negative Consequences Scale Time: Week 4 TreatmentDescription: This measure is an 8-item patient-rated index of substance use severity. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Not at all) to 5 (Almost Always).
Measure: PROMIS Alcohol Negative Consequences Scale Time: Week 5 Follow-upDescription: This measure is an 8-item patient-rated index of substance use severity. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Not at all) to 5 (Almost Always).
Measure: PROMIS Alcohol Negative Consequences Scale Time: Week 6 Follow-upDescription: This measure is an 8-item patient-rated index of sleep disturbance. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Not at all) to 5 (Very Much).
Measure: PROMIS Sleep Disturbance Scale Time: Week 0 BaselineDescription: This measure is an 8-item patient-rated index of sleep disturbance. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Not at all) to 5 (Very Much).
Measure: PROMIS Sleep Disturbance Scale Time: Week 1 TreatmentDescription: This measure is an 8-item patient-rated index of sleep disturbance. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Not at all) to 5 (Very Much).
Measure: PROMIS Sleep Disturbance Scale Time: Week 2 TreatmentDescription: This measure is an 8-item patient-rated index of sleep disturbance. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Not at all) to 5 (Very Much).
Measure: PROMIS Sleep Disturbance Scale Time: Week 3 TreatmentDescription: This measure is an 8-item patient-rated index of sleep disturbance. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Not at all) to 5 (Very Much).
Measure: PROMIS Sleep Disturbance Scale Time: Week 4 TreatmentDescription: This measure is an 8-item patient-rated index of sleep disturbance. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Not at all) to 5 (Very Much).
Measure: PROMIS Sleep Disturbance Scale Time: Week 5 Follow-upDescription: This measure is an 8-item patient-rated index of sleep disturbance. Each item is rated over a 7-day period on a 5-point scale ranging from 1 (Not at all) to 5 (Very Much).
Measure: PROMIS Sleep Disturbance Scale Time: Week 6 Follow-upDescription: This measure is a 12-item author-constructed patient-rated index of COVID-19 Coping Self-Efficacy
Measure: COVID-19 Coping Self-Efficacy Time: Week 0 BaselineDescription: This measure is a 12-item author-constructed patient-rated index of COVID-19 Coping Self-Efficacy
Measure: COVID-19 Coping Self-Efficacy Time: Week 1 TreatmentDescription: This measure is a 12-item author-constructed patient-rated index of COVID-19 Coping Self-Efficacy
Measure: COVID-19 Coping Self-Efficacy Time: Week 2 TreatmentDescription: This measure is a 12-item author-constructed patient-rated index of COVID-19 Coping Self-Efficacy
Measure: COVID-19 Coping Self-Efficacy Time: Week 3 TreatmentDescription: This measure is a 12-item author-constructed patient-rated index of COVID-19 Coping Self-Efficacy
Measure: COVID-19 Coping Self-Efficacy Time: Week 4 TreatmentDescription: This measure is a 12-item author-constructed patient-rated index of COVID-19 Coping Self-Efficacy
Measure: COVID-19 Coping Self-Efficacy Time: Week 5 Follow-upDescription: This measure is a 12-item author-constructed patient-rated index of COVID-19 Coping Self-Efficacy
Measure: COVID-19 Coping Self-Efficacy Time: Week 6 Follow-upAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports